The β2-adrenergic receptor specifically sequesters Gs but signals through both Gs and Gi/o in rat sympathetic neurons

Neuroscience

Volumn 118, Issue 3, 2003, Pages 603-610

  Vasquez C ^a,b   Lewis, D L ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSIDAD DE COLIMA   (Mexico)

Author keywords

CB1 cannabinoid; Constitutively active; Cross talk; G protein sequestration; G protein coupled receptors; VIP

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CANNABINOID 1 RECEPTOR; CHOLERA TOXIN; COMPLEMENTARY DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; PERTUSSIS TOXIN; VASOACTIVE INTESTINAL POLYPEPTIDE; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CANNABINOID RECEPTOR; DIAGNOSTIC AGENT; DRUG RECEPTOR; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; DRUG EFFECT; MALE; MICROINJECTION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; SUPERIOR CERVICAL GANGLION; SYMPATHETIC NERVE; ANIMAL; CALCIUM SIGNALING; CELL CULTURE; CYTOLOGY; GENETICS; METABOLISM; NERVE CELL; PHYSIOLOGY; WISTAR RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; CALCIUM SIGNALING; CELLS, CULTURED; CHOLERA TOXIN; DNA, COMPLEMENTARY; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HETEROTRIMERIC GTP-BINDING PROTEINS; MALE; NEURONS; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SIGNAL TRANSDUCTION; SUPERIOR CERVICAL GANGLION; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0042766878     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00024-1     Document Type: Article

References (28)

1. Ango F., Prézeau L., Muller T., Tu J.C., Xiao B., Worley P.F., Pin J.P., Bockaer J., Fagni L. Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer. Nature. 411:2001;962-965.
2. 2-adrenoceptor. Nature. 374:1995;272-276.
3. Bouaboula M., Perrachon S., Milligan L., Canat X., Rinaldi-Carmona M., Portier M., Barth F., Calandra B., Pecceu F., Lupker J., Maffrand J.P., Le Fur G., Casellas P. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-actived protein kinase activation stimulated by insulin or insulin-like growth factor 1 evidence for a new model of receptor/ligand interactions . J Biol Chem. 272:1997;22330-22339.
4. 1A dopamine receptor from Gs protein . Mol Pharmacol. 56:1999;989-996.
5. Chidiac P., Hebert T.E., Valiquette M., Dennis M., Bouvier M. Inverse agonist activity of β-adrenergic antagonists. Mol Pharmacol. 45:1994;490-499.
6. Claeysen S., Sebben M., Bécamel C., Eglen R.M., Clark R.D., Bockaert J., Dumuis A. Pharmacological properties of 5-hydroxytryptamine4 receptor antagonists on constitutively active wild-type and mutated receptors. Mol Pharmacol. 58:2000;136-144.
7. Costa T., Herz A. Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins. Proc Natl Acad Sci USA. 86:1989;7321-7325.
8. 2-adrenergic receptor to different G proteins by protein kinase A. Nature. 390:1997;88-91.
9. Demchyshyn L.L., McConkey F., Niznik H.B. Dopamine D5 receptor agonist high affinity and constitutive activity profile conferred by carboxyl-terminal tail sequence. J Biol Chem. 275:2000;23446-23455.
10. Ehlert F.J. 'Inverse agonists,' cooperativity and drug action at benzodiazepine receptors. Trends Pharmacol Sci. 7:1986;28-32.
11. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391:1981;85-100.
12. Ikeda S.R., Dunlap K. Voltage-dependent modulation of N-type calcium channels role of G protein subunits . Adv Second Messenger Phosphoprotein Res. 33:1999;131-151.
13. 1 receptor. Eur J Pharmacol. 334:1997;R1-R2.
14. MacLennan S.J., Reynen P.H., Kwan J., Bonhaus D.W. Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors. Br J Pharmacol. 124:1998;619-622.
15. McLoughlin D.J., Strange P.G. Mechanisms of agonism and inverse agonism at serotonin 5-HT1A receptors. J Neurochem. 74:2000;347-357.
16. Milligan G., Unson C.G., Wakelam M.J.A. Cholera toxin treatment produces down-regulation of the alpha-subunit of the stimulatory guanine-nucleotide-binding protein (Gs). Biochem J. 262:1989;643-649.
17. Morisset S., Rouleau A., Ligneau X., Gbahou F., Tardivel-Lacombe J., Stark H., Schunack W., Ganellin C.R., Schwartz J.-C., Arrang J.-M. High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature. 401:2000;860-864.
18. Mukhopadhyay S., McIntosh H.H., Houston D.B., Howlett A.C. The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain. Mol Pharmacol. 57:2000;162-170.
19. Mukhopadhyay S., Howlett A.C. CB1 receptor-G protein association. Subtype selectivity is determined by distinct intracellular domains Eur J Biochem. 268:2001;499-505.
20. 2+ currents by reversal of tonic CB1 cannabinoid receptor activity. Mol Pharmacol. 54:1998;1064-1072.
21. 2-adrenergic receptor. Mol Pharmacol. 45:1994;390-394.
22. 2-adrenoceptor. Eur J Pharmacology. 180:1990;37-47.
23. 2+ current in rat sympathetic neurons via a G-protein. Eur J Pharmacol. 207:1991;195-207.
24. 2A-adenosine receptor in primary human endothelial cells. J Biol Chem. 272:1997;5792-5799.
25. Vásquez C., Lewis D.L. The CB1 cannabinoid receptor can sequester G proteins making them unavailable to couple to other receptors. J Neurosci. 19:1999;9271-9280.
26. 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol. 47:1995;322-329.
27. i proteins and its physiological relevance in murine cardiac myocytes. Circ Res. 84:1999;43-52.
28. 2+ channels of sympathetic neurons via a pertussis toxin-insensitive but cholera toxin-sensitive pathway. Neuron. 13:1994;657-669.